For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and sometimes fatal illness stiffens and scars tissue in organs like the lungs, ...

Please provide your email address to receive an email when new articles are posted on . Nearly 10% of patients with systemic sclerosis had systemic sclerosis sine scleroderma, a subtype without skin ...

Detection of certain auto-antibodies flagged patients with scleroderma (also known as systemic sclerosis) who were especially likely to develop pulmonary hypertension over long-term follow-up, a ...

Please provide your email address to receive an email when new articles are posted on . Interstitial lung disease and pulmonary arterial hypertension associated with scleroderma often require ...

Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as scleroderma and graft-versus-host disease. Subscribe to our newsletter for ...

A chance meeting in a crowded cafeteria led to a scientific discovery that someday could help millions of people with fibrotic diseases. The two scientists who met over lunch later discovered a blood ...

Ocean’s small molecule candidate significantly controls fibrosis progression in idiopathic pulmonary fibrosis (IPF) and Hermansky-Pudlak Syndrome (HPS) in multiple testing models. Patent granted for ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

Lab-grown skin captures the complexities of real disease to develop more effective treatments for scleroderma and other life-threatening conditions. For the 300,000 Americans living with the immune ...